Subgrouping of intermediate-stage (BCLC stage B) hepatocellular carcinoma based on tumor number and size and Child–Pugh grade correlated with prognosis after transarterial chemoembolization

被引:3
|
作者
Koichiro Yamakado
Shiro Miyayama
Shozo Hirota
Kimiyoshi Mizunuma
Kenji Nakamura
Yoshitaka Inaba
Hiroaki Maeda
Kunihiro Matsuo
Norifumi Nishida
Takeshi Aramaki
Hiroshi Anai
Shinichi Koura
Shigeo Oikawa
Ken Watanabe
Taku Yasumoto
Kinya Furuichi
Masato Yamaguchi
机构
[1] Mie University,Department of Interventional Radiology, School of Medicine
[2] Fukui-ken Saiseikai Hospital,Department of Diagnostic Radiology
[3] Hyogo College of Medicine,Department of Radiology
[4] Ohtawara Red Cross Hospital,Department of Radiology
[5] Daito Central Hospital,Department of Radiology
[6] Aichi Cancer Center Hospital and Research Institute,Department of Diagnostic and Interventional Radiology
[7] Narumi Hospital,Department of Radiology
[8] Osaka City University,Department of Radiology
[9] Shizuoka Cancer Center,Department of Diagnostic Radiology
[10] Nara Medical University,Department of Radiology
[11] Fukuoka University,Department of Radiology
[12] Iwate Prefectural Central Hospital,Department of Radiology
[13] Jikei University,Department of Radiology
[14] Toyonaka Municipal Hospital,Department of Radiology
[15] Higashiosaka City General Hospital,Department of Radiology
[16] Kobe University,Department of Radiology
来源
关键词
Hepatocellular carcinoma; Arterial embolization; Prognosis; Child–Pugh grade; Tumor number; Tumor diameter;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:260 / 265
页数:5
相关论文
共 50 条
  • [21] Prognosis of patients with intermediate-stage hepatocellular carcinomas based on the Child-Pugh score: subclassifying the intermediate stage (Barcelona Clinic Liver Cancer stage B)
    Koichiro Yamakado
    Shiro Miyayama
    Shozo Hirota
    Kimiyoshi Mizunuma
    Kenji Nakamura
    Yoshitaka Inaba
    Satoshi Yamamoto
    Kunihiro Matsuo
    Norifumi Nishida
    Takeshi Aramaki
    Hiroshi Anai
    Shinichi Kora
    Shigeo Oikawa
    Ken Watanabe
    Taku Yasumoto
    Kinya Furuichi
    Masato Yamaguchi
    Japanese Journal of Radiology, 2014, 32 : 644 - 649
  • [22] Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma
    Wada, Hiroshi
    Eguchi, Hidetoshi
    Noda, Takehiro
    Ogawa, Hisataka
    Yamada, Daisaku
    Tomimaru, Yoshito
    Tomokuni, Akira
    Asaoka, Tadafumi
    Kawamoto, Koichi
    Gotoh, Kunihito
    Marubashi, Shigeru
    Umeshita, Koji
    Nagano, Hiroaki
    Doki, Yuichiro
    Mori, Masaki
    SURGERY, 2016, 160 (05) : 1227 - 1235
  • [23] Prognosis of patients with intermediate-stage hepatocellular carcinomas based on the Child-Pugh score: subclassifying the intermediate stage (Barcelona Clinic Liver Cancer stage B)
    Yamakado, Koichiro
    Miyayama, Shiro
    Hirota, Shozo
    Mizunuma, Kimiyoshi
    Nakamura, Kenji
    Inaba, Yoshitaka
    Yamamoto, Satoshi
    Matsuo, Kunihiro
    Nishida, Norifumi
    Aramaki, Takeshi
    Anai, Hiroshi
    Kora, Shinichi
    Oikawa, Shigeo
    Watanabe, Ken
    Yasumoto, Taku
    Furuichi, Kinya
    Yamaguchi, Masato
    JAPANESE JOURNAL OF RADIOLOGY, 2014, 32 (11) : 644 - 649
  • [24] Effectiveness of sorafenib in treating intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization
    Ashour, Reham
    Rewisha, Eman
    Rady, Mohamed A. K. L.
    Elkhadry, Sally Waheed
    Abdelhalim, Heba
    Atef, Mohamed
    BMC CANCER, 2024, 24 (01)
  • [25] Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study
    Lu, Linbin
    Zheng, Peichan
    Wu, Zhixian
    Chen, Xiong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] Surgical Resection Versus Transarterial Chemoembolization for Intermediate Stage Hepatocellular Carcinoma (BCLC-B): An Unsolved Question
    Labgaa, Ismail
    Demartines, Nicolas
    Melloul, Emmanuel
    HEPATOLOGY, 2019, 69 (02) : 923 - 923
  • [27] Optimal timing of radiotherapy for incomplete transarterial chemoembolization in BCLC stage B hepatocellular carcinoma
    Byun, Hwa Kyung
    Kim, Nalee
    Seong, Jinsil
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [28] Proton beam therapy versus Transarterial chemoembolization for BCLC Stage B Hepatocellular Carcinoma
    Liu, Tzu-Ting
    Cheng, Jen-Yu
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2184 - S2186
  • [29] A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma
    Lin, Huapeng
    Zeng, Lingfeng
    Yang, Jing
    Hu, Wei
    Zhu, Ying
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [30] A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma
    Lee, I-Cheng
    Hung, Ya-Wen
    Liu, Chien-An
    Lee, Rheun-Chuan
    Su, Chien-Wei
    Huo, Teh-la
    Li, Chung-Pin
    Chao, Yee
    Lin, Han-Chieh
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    LIVER INTERNATIONAL, 2019, 39 (09) : 1704 - 1712